BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20132579)

  • 1. [Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007].
    Voorham J; Haaijer-Ruskamp FM; van der Meer K; de Zeeuw D; Wolffenbuttel BH; Hoogenberg K; Denig P
    Ned Tijdschr Geneeskd; 2010; 154():A775. PubMed ID: 20132579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study.
    Voorham J; Haaijer-Ruskamp FM; van der Meer K; de Zeeuw D; Wolffenbuttel BH; Hoogenberg K; Denig P;
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1078-86. PubMed ID: 20687048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes in primary care in belgium: need for structured shared care.
    Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care].
    Gruppo di studio ANNALI AMD
    Epidemiol Prev; 2011; 35(1):18-26. PubMed ID: 21436491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups.
    Sidorenkov G; van Boven JFM; Hoekstra T; Nijpels G; Hoogenberg K; Denig P
    Diabetes Obes Metab; 2018 Aug; 20(8):1957-1964. PubMed ID: 29687577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care delivery in type 2 diabetes. A survey in an Italian primary care practice.
    Modesti A; Bartaloni R; Bellagamba F; Caglieri R; Cenori K; Ciampalini G; Costagli A; Galloni V; Del Papa C; Modesti L; Dell'Omo G; Pedrinelli R
    Prim Care Diabetes; 2015 Feb; 9(1):9-14. PubMed ID: 24908631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New treatment strategies for type-2 diabetes?].
    Halimi S
    Presse Med; 2005 Oct; 34(18):1287-92. PubMed ID: 16269991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness.
    Sidorenkov G; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
    PLoS One; 2011; 6(9):e24278. PubMed ID: 21931669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
    Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
    Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.
    Liu L; Lou Q; Guo X; Yuan L; Shen L; Sun Z; Zhao F; Dai X; Huang J; Yang H; Mordes JP;
    Diabetes Metab Res Rev; 2015 Nov; 31(8):811-6. PubMed ID: 26455830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia.
    Mengual L; Roura P; Serra M; Montasell M; Prieto G; Bonet S
    Cardiovasc Diabetol; 2010 Mar; 9():14. PubMed ID: 20350315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study.
    Fan M; Stephan AJ; Emmert-Fees K; Peters A; Laxy M
    Diabetologia; 2023 Sep; 66(9):1693-1704. PubMed ID: 37391625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Br J Gen Pract; 2009 Jan; 59(558):43-8. PubMed ID: 19105915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.
    Minutolo R; Sasso FC; Chiodini P; Cianciaruso B; Carbonara O; Zamboli P; Tirino G; Pota A; Torella R; Conte G; De Nicola L
    J Hypertens; 2006 Aug; 24(8):1655-61. PubMed ID: 16877970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.